ISPOR - PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN- A PROSPECTIVE ANALYSIS

Full Text

PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN- A PROSPECTIVE ANALYSIS

Abstract

Authors

DA Hughes S Al-Zubiedi A Hanson A Jorgensen M Pirmohamed

Back to Volume 12, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now